Post by : Saif
Al-Najjar
A bipartisan coalition of U.S. senators is pressing the Trump administration for quicker action in formulating a science-driven bird flu vaccine for livestock. Their call to action comes as the nation grapples with one of its most severe animal health crises in recent history.
Since the onset of 2022, over 180 million birds, including chickens and turkeys, have succumbed to the ongoing bird flu outbreak. This situation has devastated farmers, inflated egg prices, and fostered anxiety within the poultry sector. While the U.S. Department of Agriculture (USDA) announced in June plans for a national vaccination strategy, it has yet to clarify the timeline or specifics for its implementation.
In a letter dispatched to Agriculture Secretary Brooke Rollins on Wednesday, 23 senators urged the USDA to take “renewed action” as avian flu incidents escalate with the winter months approaching. This bipartisan group encompasses both Democrats and Republicans, indicating a unified concern across the political spectrum.
Leading the letter were Senator Amy Klobuchar of Minnesota, the top Democrat on the Senate Agriculture Committee, and Senator Mike Rounds, a South Dakota Republican. Other signers included Senate Majority Leader John Thune and several Agriculture Committee members.
The senators emphasized that any eventual vaccine initiative must be informed by scientific research and developed in collaboration with veterinarians, industry stakeholders, and animal health authorities. They also reiterated the importance of transparency to assure farmers and exporters of the potential impacts of vaccination on trade.
This year, the USDA allocated $100 million for research on bird flu vaccines for egg-laying chickens. The agency received over 400 proposals to utilize these funds, but as of June, updates on project selection or vaccination strategies remain absent.
The confusion deepened when the Trump administration canceled a $700 million agreement with Moderna in May to create a human bird flu vaccine. Health Secretary Robert F. Kennedy Jr., known for his anti-vaccine stance, has halted other federal vaccine initiatives, raising questions about the government’s readiness to combat both animal and human health challenges posed by bird flu.
The poultry sector itself is split on the necessity of vaccinating birds. Some farmers advocate for vaccination as a means to curb the outbreak, while others are concerned it might damage export markets due to restrictions on imports from vaccinated animals. The senators urged Secretary Rollins to engage with trading partners and producers to fully assess the trade implications of any vaccine framework.
By late November, the USDA confirmed that no vaccination strategy had yet been communicated to international trade partners, causing considerable uncertainty for numerous farmers as they plan for the upcoming months.
The situation reflects a broader dilemma: achieving a balance between safeguarding American agricultural interests and upholding beneficial trade relations. As winter approaches and cases continue to rise, urgency mounts for the USDA to establish a transparent and scientific approach to vaccine development.
For the time being, lawmakers, farmers, and consumers await decisive action from the federal government to mitigate an outbreak that has already inflicted significant economic and agricultural harm.
English
